Ontology highlight
ABSTRACT:
SUBMITTER: Peng M
PROVIDER: S-EPMC7873600 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Frontiers in oncology 20210127
Bladder cancer is the ninth most frequently diagnosed cancer world-wide and ranks 13th in cancer-related deaths. Two tremendous breakthroughs in bladder cancer therapy over the last decades are the approval of immune checkpoint inhibitors(ICIs)and the fibroblast growth factor receptor tyrosine kinase inhibitor (FGFR-TKI) erdafitinib for treating this deadly disease. Despite the beneficial effects of these approaches, the low response rate and the potential resistance of the cancer are major conc ...[more]